Verflixt! Es sieht so aus, als wenn Sie einen veralteten Browser benutzen. Wir empfehlen Ihnen dringend Ihren Browser zu aktualisieren.
Weitere Informationen über Browser und Updates finden Sie hier

sterna biologicals GmbH & Co. KG

Biomedizinisches Forschungszentrum (BMFZ)

sterna biologicals’ is a new biotech company focusing on the development of a novel generation of antisense drugs – termed DNAzymes - for the causative treatment of chronic inflammatory diseases, in particular bronchial asthma, atopic dermatitis and autoimmune diseases.

Based on more than a decade of biological and medical research sterna biologicals’ was founded as a spin-off of the TransMIT GmbH - Center for Immunomodulation (an institution promoting the transfer of academic research results into economic applications), and the Department of Clinical Chemistry and Molecular Diagnostics of the Philipps University of Marburg.

sterna biologicals’ facilities are embedded in a well organized infrastructure closely connected to the Research Campus of the Medical Faculty of the Philipps University of Marburg that allows for a cost and time efficient translational process from bench to bed side.

Details


Adresse:
sterna biologicals GmbH & Co. KG
Biomedizinisches Forschungszentrum (BMFZ)
Neue Kasseler Straße 62c
Forum Marburg
35043 Marburg
Deutschland
Arbeitsgebiet:
Klinische Forschung
Forschung & Lehre
Klinik & Praxis
Expansion:
national
Mitarbeiteranzahl:
1-10
Gründungsjahr:
2006